Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer DTC Guidelines Include New Brief Summary Format

Executive Summary

Pfizer intends to use a new "brief summary" format in its direct-to-consumer advertisements, the company said in an Aug. 11 announcement of changes to its DTC policy

You may also be interested in...



DTC Guideline Implementation: Does “Ask Your Doctor” Spark A Dialogue?

As industry continues to implement PhRMA's guidelines on direct-to-consumer ads, debate has arisen as to how companies can effectively enact the principle that advertising should encourage a conversation between patient and physician

DTC Guideline Implementation: Does “Ask Your Doctor” Spark A Dialogue?

As industry continues to implement PhRMA's guidelines on direct-to-consumer ads, debate has arisen as to how companies can effectively enact the principle that advertising should encourage a conversation between patient and physician

AstraZeneca Questions Value Of DTC Ads, But Is Still Launching New TV Spots

AstraZeneca will soon have both experimental and marketplace data to help refine its new policies on direct-to-consumer advertising

Related Content

Topics

UsernamePublicRestriction

Register

OM016276

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel